Who Paid My Doc
Larry Baker
Oral & Maxillofacial Surgery Hastings, NE Doctor of Dentistry
NPI 1508967639 CMS profile 1174909
501 W 9Th St, Hastings, NE 68901
General payments
$1,227
Research payments
$0
Ownership & investment interest
$0
Through program year 2022, Larry Baker of Hastings, NE is reported in the CMS Open Payments database as having received $1,227 across 20 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 56th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2022 | General | $1,227 | 20 |
Beside peers
- Larry Baker
- Oral & Maxillofacial Surgery median
- Middle half of Oral & Maxillofacial Surgery
- National median
In program year 2025, general payments to Larry Baker were reported at $0. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.
Show as a table
| Year | Larry Baker | Oral & Maxillofacial Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $178 | $56–$584 | $163 |
| 2020 | $0 | $106 | $38–$316 | $114 |
| 2021 | $0 | $165 | $57–$511 | $132 |
| 2022 | $1,227 | $173 | $63–$494 | $149 |
| 2023 | $0 | $184 | $62–$521 | $160 |
| 2024 | $0 | $197 | $65–$603 | $164 |
| 2025 | $0 | $184 | $61–$541 | $169 |
Breakdown
Prescribing to Medicare patients
Part D · data year 2024 · 1 drugPart D claims
16
Drug cost
$4,534
Branded share of claims
100%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Eliquis Apixaban | Brand | 16 | $4,534 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 692 Part D prescribers listed as Maxillofacial Surgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 18 billing codesPaid by Medicare
$6,654
Medicare patients
31
Services billed
57
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 58% | |
| Diabetes | 42% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
20 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Oral & Maxillofacial Surgery in Nebraska
Matthew Weber
Oral & Maxillofacial Surgery · Kearney, NE
Adam Robinson
Oral & Maxillofacial Surgery · Omaha, NE
Jiasheng Guo
Oral & Maxillofacial Surgery · Omaha, NE
Christopher Treinen
Oral & Maxillofacial Surgery · Omaha, NE
John Wewel
Oral & Maxillofacial Surgery · Omaha, NE
Jason Untrauer
Oral & Maxillofacial Surgery · Omaha, NE
Related records
Oral & Maxillofacial Surgery in Nebraska
Practitioners in the same specialty and state, ranked by reported value.
All Oral & Maxillofacial Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Nebraska
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.